Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stran & Company (SWAG) Cash & Equivalents (2020 - 2026)

Stran & Company has reported Cash & Equivalents over the past 7 years, most recently at $7.6 million for Q1 2026.

  • Quarterly results put Cash & Equivalents at $7.6 million for Q1 2026, up 80.55% from a year ago — trailing twelve months through Mar 2026 was $7.6 million (up 80.55% YoY), and the annual figure for FY2025 was $6.8 million, down 27.84%.
  • Cash & Equivalents reached $7.6 million in Q1 2026 per SWAG's latest filing, up from $6.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $40.0 million in Q1 2022 and bottomed at -$73000.0 in Q3 2023.
  • Median Cash & Equivalents over the past 5 years was $10.0 million (2024), compared with a mean of $11.8 million.
  • The largest annual shift saw Cash & Equivalents tumbled 100.59% in 2023 before it soared 14078.79% in 2024.
  • Over 5 years, Cash & Equivalents stood at $15.3 million in 2022, then tumbled by 99.57% to $66000.0 in 2023, then skyrocketed by 14078.79% to $9.4 million in 2024, then decreased by 27.84% to $6.8 million in 2025, then rose by 13.25% to $7.6 million in 2026.
  • Business Quant data shows Cash & Equivalents for SWAG at $7.6 million in Q1 2026, $6.8 million in Q4 2025, and $6.7 million in Q3 2025.